Evaluating changes in stable chromosomal translocation frequency in patients receiving radioimmunotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 46, Issue 3, 2000, Pages 599-607

  Wong, Jeffrey Y C ^a   Wang, Jianyi ^a   Liu, An ^a   Odom Maryon, Tamara ^a   Shively, John E ^a   Raubitschek, Andrew A ^a   Williams, Lawrence E ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Chromosomes; Dose response; Fluorescence in situ hybridization; Radioimmunotherapy; Stable translocations

Indexed keywords

ADENOCARCINOMA; ARTICLE; BLOOD TOXICITY; CHROMOSOME TRANSLOCATION; DOSIMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; WHOLE BODY RADIATION;

BONE MARROW; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 4; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; PROSTATIC NEOPLASMS; RADIOIMMUNOTHERAPY; REGRESSION ANALYSIS; TRANSLOCATION, GENETIC;

EID: 0033982673     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00400-9     Document Type: Article

References (31)

1. Press O.W., Eary J.F., Appelbaum F.R., et al. Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support [see comments]. N Engl J Med. 329:1993;1219-1224.
2. Schrier D.M., Stemmer S.M., Johnson T., et al. High-dose 90Y Mx-diethylenetriaminepentaacetic acid (DTPA)-BrE-3 and autologous hematopoietic stem cell support (AHSCS) for the treatment of advanced breast cancer A phase I trial . Cancer Res. 55:1995;5921s-5924s.
3. Erdi Y.E., Wessels B.W., Loew M.H., Erdi A.K. Threshold estimation in single photon emission computed tomography and planar imaging for clinical radioimmunotherapy. Cancer Res. 55:1995;5823s-5826s.
4. Richman C.M., DeNardo S.J., O'Grady L.F., DeNardo G.L. Radioimmunotherapy for breast cancer using escalating fractionated doses of 131I-labeled chimeric L6 antibody with peripheral blood progenitor cell transfusions. Cancer Res. 55:1995;5916s-5920s.
5. 90yttrium radiolabeled anti-CEA chimeric T84.66 in a phase I radioimmunotherapy trial. Cancer Res. 55:1995;5929s-5934s.
6. Lim S.M., DeNardo G.L., DeNardo D.A., et al. Prediction of myelotoxicity using radiation doses to marrow from body, blood and marrow sources. J Nucl Med. 38:1997;1374-1378.
7. Breitz H.B., Fisher D.R., Wessels B.W. Marrow toxicity and radiation absorbed dose estimates from rhenium-186-labeled monoclonal antibody. J Nucl Med. 39:1998;1746-1751.
8. Sgouros G., Divgi C.R., Scott A.M., Williams J.A., Larson S.M. Hematologic toxicity in radioimmunotherapy An evaluation of different predictive measures . J Nucl Med. 37:1996;43P-44P.
9. Tucker J.D., Ramsey M.J., Lee D.A., Minkler J.L. Validation of chromosome painting as a biodosimeter in human peripheral lymphocytes following acute exposure to ionizing radiation in vitro. Int J Radiat Biol. 64:1993;27-37.
10. Tucker J.D., Lee D.A., Moore D.H. Validation of chromosome painting. II. A detailed analysis of aberrations following high doses of ionizing radiation in vitro. Int J Radiat Biol. 67:1995;19-28.
11. Fernandez J.L., Campos A., Goyanes V., Losada C., Veiras C., Edwards A.A. X-ray biological dosimetry performed by selective painting of human chromosomes 1 and 2. Int J Radiat Biol. 67:1995;295-302.
12. Stram D.O., Sposto R., Preston D., Abrahamson S., Honda T., Awa A.A. Stable chromosome aberrations among A-bomb survivors An update . Radiat Res. 136:1993;29-36.
13. Salassidis K., Georgiadou-Schumacher V., Braselmann H., Muller P., Peter R.U., Bauchinger M. Chromosome painting in highly irradiated Chernobyl victims A follow-up study to evaluate the stability of symmetrical translocations and the influence of clonal aberrations for retrospective dose estimation . Int J Radiat Biol. 68:1995;257-262.
14. Lindholm C., Tekkel M., Veidebaum T., Ilus T., Salomaa S. Persistence of translocations after accidental exposure to ionizing radiation. Int J Radiat Biol. 74:1998;565-571.
15. Smith L.M., Evans J.W., Mori M., Brown J.M. The frequency of translocations after treatment for Hodgkin's disease. Int J Radiat Oncol Biol Phys. 24:1992;737-742.
16. Kovacs M.S., Evans J.W., Johnstone I.M., Brown J.M. Radiation-induced damage, repair and exchange formation in different chromosomes of human fibroblasts determined by fluorescence in situ hybridization. Radiat Res. 137:1994;34-43.
17. Brown J.M., Evans J., Kovacs M.S. The prediction of human tumor radiosensitivity in situ An approach using chromosome aberrations detected by fluorescence in situ hybridization . Int J Radiat Oncol Biol Phys. 24:1992;279-286.
18. Gray J.W., Pinkel D., Brown J.M. Fluorescence in situ hybridization in cancer and radiation biology. Radiat Res. 137:1994;275-289.
19. Yan XW, Wong JYC. Frequency of stable chromosomal translocations after external beam and radiolabeled antibody irradiation. 42nd Annual Meeting of the Radiation Research Society, Nashville, TN, 1994;140.
20. Odom-Maryon T.L., Chai A., Williams L.E., et al. Pharmacokinetics modeling and absorbed dose estimation for a chimeric anti-CEA antibody (cT84.66) in humans. J Nucl Med. 38:1997;1959-1966.
21. Loevinger R., Berman M. MIRD Pamphlet No. 1. J Nucl Med. 9:(Suppl. 1):1968;7-14.
22. Stabin M.G. MIRDOSE Personal computer software for internal dose assessment in nuclear medicine . J Nucl Med. 37:1996;538-546.
23. Williams L.E., Primus F.J., Wong J.Y.C., et al. Biodistribution of an In-111 or Y-90 labeled chimeric anti-CEA monoclonal antibody (cT84.66) following its large scale production in a bioreactor. Tumor Targeting. 2:1996;116-124.
24. Clarke K.G., Odom-Maryon T.L., Williams L.E., et al. Intrapatient consistency of imaging biodistributions and their application to predicting therapeutic doses in a phase I clinical study of 90Y-based radioimmunotherapy. Med Phys. 26:1999;799-809.
25. Siegel J.A., Wessels B.W., Watson E.E., et al. Bone marrow dosimetry and toxicity for radioimmunotherapy. Antibody Immunoconj Radiopharm. 3:1990;213-233.
26. Zar J.H. Simple linear regression. Kurtz B. Biostatistical analysis. 1984;261-271 Prentice Hall, Englewood Cliffs, NJ.
27. Zar J.H. Polynomial regression. Kurtz B. Biostatistical analysis. 1984;366-367 Prentice Hall, Englewood Cliffs, NJ.
28. Diggle P.J., Liang K.Y., Zegar S.L. General linear models for longitudinal data. Atkinson A.C., Copas J.B., Pierce D.A., Schervish M.J., Tiiterington D.M. Analysis of longitudinal data. 1995;55-77 Oxford University Press, New York.
29. Diggle P.J., Liang K.Y., Zegar S.L. Parametric models for covariance structure. Atkinson A.C., Copas J.B., Pierce D.A., Schervish M.J., Tiiterington D.M. Analysis of longitudinal data. 1995;78-87 Oxford University Press, New York.
30. SAS/STAT User's Guide (version 6). 4th(2), 846. 1989. Cary, North Carolina: SAS Institute, Inc.
31. S-PLUS. 1998. Seattle, WA: Math Soft, Inc., Data Analysis Products Division.